DiaSorin S p A : Half-Year Financial Report at June 30, 2023

HALF-YEAR FINANCIAL REPORT

JUNE 30, 2023

DiaSorin S.p.A.

Via Crescentino (no building No.) - 13040 Saluggia (VC) Tax I.D. and Vercelli Company Register n. 13144290155

Contents
DIASORIN WORLD
1. BOARD OFDIRECTORS& CONTROLBODIES	........................................................................................ 3
2. DIASORIN WORLDWIDE	4
3. THE DIASORIN GROUP	5
4. OUR BUSINESS	6
THE GROUP'S TECHNOLOGIES
1. IMMUNODIAGNOSTICS	7
2. MOLECULAR DIAGNOSTICS	7
3. LICENSED TECHNOLOGIES	9
4. RESEARCH AND DEVELOPMENT	9
OVERVIEW OF THE RESULTS
1 CONSOLIDATED FINANCIAL HIGHLIGHTS	11

2. OVERVIEW OF THE GROUP'S PERFORMANCE IN THE FIRST HALF OF 2023 AND COMPARISON WITH 2022

................................................................................................................................................................	12
3. REVIEW OF THE GROUP'S OPERATING PERFORMANCE AND FINANCIAL POSITION	15
4. STATEMENT OF FINANCIAL POSITION AT JUNE 30, 2023	20
5. TRANSACTIONS RESULTING FROM NON-RECURRING, ATYPICAL AND/OR UNUSUAL OPERATIONS ....	23
6. MAIN RISKS AND UNCERTAINTIES TO WHICH DIASORIN S.P.A AND THE GROUP ARE EXPOSED	23
7. SIGNIFICANT EVENTS OCCURRED AFTER JUNE 30, 2023 AND BUSINESS OUTLOOK	26
8. RELATED-PARTYTRANSACTIONS	26
CONDENSED HALF-YEAR CONSOLIDATED FINANCIAL
STATEMENTS AT JUNE 30, 2023
1.	CONSOLIDATED INCOME STATEMENT	27
2.	CONSOLIDATED COMPREHENSIVE INCOME STATEMENT	28
3.	CONSOLIDATED STATEMENT OF FINANCIAL POSITION	29
4.	CONSOLIDATED STATEMENT OF CASH FLOWS	31
5.	STATEMENT OF CHANGES IN CONSOLIDATED SHAREHOLDERS' EQUITY	32
6.	NOTES TO THE CONDENSED HALF-YEAR CONSOLIDATED FINANCIAL STATEMENTS	33
7.	ANNEX I: THE COMPANIES OF THE DIASORIN GROUP AT JUNE 30, 2023	60

8. CERTIFICATION TO THE CONDENSED HALF-YEAR CONSOLIDATED FINANCIAL

STATEMENTS

61

2

DIASORIN WORLD

1. BOARD OF DIRECTORS & CONTROL BODIES

BOARD OF DIRECTORS (appointed on April 29, 2022)

Chairman	Michele Denegri
Deputy Chairman	Giancarlo Boschetti
Chief Executive Officer	Carlo Rosa (1)
Directors	Chen Menachem Even
	Stefano Altara
	Luca Melindo
	Diego Pistone
	Fiorella Altruda (2)
	André Michel Ballester (2)(3)
	Franco Moscetti
	Francesca Pasinelli (2)
	Roberta Somati (2)
	Monica Tardivo (2)
	Tullia Todros (2)
	Giovanna Pacchiana Parravicini (2)
BOARD OF STATUTORY AUDITORS
Chairman	Monica Mannino
Statutory Auditors	Ottavia Alfano
	Matteo Michele Sutera
Alternates	Romina Guglielmetti
	Cristian Tundo
INDEPENDENT AUDITORS	PricewaterhouseCoopers S.p.A.
COMMITTEES
Control, Risk and Sustainability Committee	André Michel Ballester (2) (Chairman)
	Franco Moscetti
	Roberta Somati (2)
Remuneration and Nominating Committee	Roberta Somati (2)
	Giancarlo Boschetti
	Giovanna Pacchiana Parravicini (2)
Committee for Related-Party Transactions	Roberta Somati (2)
	André Michel Ballester (2)
	Giovanna Pacchiana Parravicini (2)
(1) General Manager
(2) Independent Director
(3) Lead Independent Director
	3

2. DIASORIN WORLDWIDE

The Group headed by DiaSorin S.p.A. operates in all continents through 39 Companies, 4 branches, 10 production sites and 9 research and development centers located around the world.

DiaSorin operates, through its direct presence, in 27 countries. The rest of the world is served through an international network of independent distributors with whom the Group maintains a constant dialogue in accordance with the best interests of its end customers.

4

3. THE DIASORIN GROUP

5